The Trump administration is expected to claw back $1.5 billion in public health and transportation funding to four states led by Democrats.
Public health authorities warn clinicians to weigh risks and enroll patients in supervised programs: routine testing, partner management, and resistance surveillance are essential.
A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage ...
Shares fell as much as 6% in after-hours trading, a decline one analyst guessed may be because Yeztugo’s trajectory isn’t matching investors’ sky-high hopes.
Guidance for HIV sales growth increased to approximately 6% for 2026, up from prior expectations, while Yeztugo's revenue ...
The Philly Keep on Loving HIV Resource Finder compiles a wide range of services administered through the Health Department ...
Florida’s AIDS Drug Assistance Program represents millions of dollars in financial assistance, ensuring that thousands of people receive yearly coverage for life-saving medication.
Sales have been falling within the company’s cell-therapy portfolio.
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2025.
The biopharmaceutical company may start to offer two cancer therapies and an additional HIV treatment option this year.
In a federally funded clinical trial led by Johns Hopkins Medicine, people with tuberculosis infections (but not HIV) in two ...
Harley Ransom began practicing harm reduction in southeastern Ontario in the late 1980s, when he was 6 years old. His ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results